Moleculin Issues New Positive AML Overall Survival Data:

Median Overall Survival (OS) of 15 months for subjects with complete remission (n=8)

Median OS of 2^nd Line efficacy evaluable population of 12 months (n=9)

Read more at globenewswire.com